We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$685M
AUM Growth
+$52.8M
Cap. Flow
-$4.48M
Cap. Flow %
-0.65%
Top 10 Hldgs %
76.51%
Holding
68
New
1
Increased
7
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$2.37M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.76M
3
MRK icon
Merck
MRK
+$1.01M
4
ABBV icon
AbbVie
ABBV
+$863K
5
ELAN icon
Elanco Animal Health
ELAN
+$418K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.78M
2
WSM icon
Williams-Sonoma
WSM
+$2.61M
3
GE icon
GE Aerospace
GE
+$1.79M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$623K
5
PFE icon
Pfizer
PFE
+$405K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.61%
2 Healthcare 34.49%
3 Communication Services 5.12%
4 Energy 4.72%
5 Technology 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$294M 42.87%
8,002,196
-75,000
-0.9% -$2.61M
ZTS icon
2
Zoetis
ZTS
$31.1B
$36.6M 5.34%
276,366
-800
-0.3% -$99.4K
DIS icon
3
Walt Disney
DIS
$179B
$32.7M 4.77%
225,900
-900
-0.4% -$126K
ABT icon
4
Abbott
ABT
$190B
$28.6M 4.18%
329,630
-3,700
-1% -$310K
BMY icon
5
Bristol-Myers Squibb
BMY
$130B
$27.5M 4.02%
428,964
+30,800
+8% +$1.76M
JNJ icon
6
Johnson & Johnson
JNJ
$626B
$23.9M 3.49%
163,780
-1,896
-1% -$257K
MRK icon
7
Merck
MRK
$322B
$23.2M 3.38%
267,292
+12,261
+5% +$1.01M
LLY icon
8
Eli Lilly
LLY
$1.08T
$20.5M 2.99%
156,106
+1,086
+0.7% +$126K
AAPL icon
9
Apple
AAPL
$4.45T
$20.4M 2.98%
277,828
– –
ABBV icon
10
AbbVie
ABBV
$442B
$17.1M 2.5%
193,570
+10,400
+6% +$863K
ZBH icon
11
Zimmer Biomet
ZBH
$18.5B
$15.2M 2.21%
104,288
-103
-0.1% -$14.2K
KMB icon
12
Kimberly-Clark
KMB
$36.1B
$14.2M 2.07%
103,300
– –
PFE icon
13
Pfizer
PFE
$152B
$14.1M 2.06%
380,119
-11,364
-3% -$405K
KMI icon
14
Kinder Morgan
KMI
$70.1B
$13.2M 1.92%
622,913
+117,064
+23% +$2.37M
MSFT icon
15
Microsoft
MSFT
$3.74T
$11.4M 1.66%
72,100
+500
+0.7% +$73.5K
BAX icon
16
Baxter International
BAX
$14.3B
$11.3M 1.66%
135,700
-1,250
-0.9% -$103K
CAT icon
17
Caterpillar
CAT
$388B
$8.86M 1.29%
60,000
– –
ELAN icon
18
Elanco Animal Health
ELAN
$11.4B
$8.6M 1.25%
291,871
+15,400
+6% +$418K
MA icon
19
Mastercard
MA
$492B
$5.97M 0.87%
20,000
– –
PG icon
20
Procter & Gamble
PG
$338B
$5.7M 0.83%
45,671
– –
CI icon
21
Cigna
CI
$72.4B
$5.36M 0.78%
26,187
-431
-2% -$79K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.11T
$4.58M 0.67%
20,210
-10
-0% -$2.17K
EPD icon
23
Enterprise Products Partners
EPD
$81.8B
$4.21M 0.61%
149,570
-8,000
-5% -$217K
TCP
24
DELISTED
TC Pipelines LP
TCP
$4.04M 0.59%
95,400
– –
MMP
25
DELISTED
Magellan Midstream Partners, L.P.
MMP
$3.44M 0.5%
54,800
-10,000
-15% -$623K
1
2 3

Similar funds

FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Blackhill Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Blackhill Capital held 68 positions worth $685M, up 8.3% from $633M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Blackhill Capital's Q4 2019 filing shows 1 new, 7 increased, 18 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 28,000 shares worth $84K. The largest sale was Celgene Corp, an estimated $2.78M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, down from 44% a quarter earlier, followed by Healthcare and Communication Services.

  • Blackhill Capital's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 28,000 shares worth $84K.
  • Blackhill Capital added most to Kinder Morgan in Q4 2019, an estimated $2.37M increase.
  • Blackhill Capital's biggest Q4 2019 reduction was Williams-Sonoma, cutting an estimated $2.61M.
  • Blackhill Capital fully exited Celgene Corp in Q4 2019, selling an estimated $2.78M.
  • Blackhill Capital's ten largest holdings make up 77% of its $685M portfolio in Q4 2019.
  • Blackhill Capital opened 1 new position and closed 5 in Q4 2019.
  • Blackhill Capital's portfolio value rose 8.3% quarter-over-quarter to $685M.

Based on Blackhill Capital's 13F filing for Q4 2019, filed 10 Feb 2020.